Abstract |
|
Authors | Jennifer Eng-Wong, Joseph P Costantino, Sandra M Swain |
Journal | Journal of the National Cancer Institute. Monographs
(J Natl Cancer Inst Monogr)
Vol. 2010
Issue 41
Pg. 200-3
( 2010)
ISSN: 1745-6614 [Electronic] United States |
PMID | 20956830
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Antineoplastic Agents, Hormonal
- Estrogens
- Receptors, Estrogen
- Selective Estrogen Receptor Modulators
- Tamoxifen
|
Topics |
- Adult
- Aged
- Antineoplastic Agents, Hormonal
(adverse effects, therapeutic use)
- Breast Neoplasms
(drug therapy, epidemiology, mortality, pathology, radiotherapy, surgery)
- Carcinoma, Intraductal, Noninfiltrating
(drug therapy, epidemiology, mortality, pathology, radiotherapy, surgery)
- Chemotherapy, Adjuvant
- Clinical Trials, Phase III as Topic
(statistics & numerical data)
- Combined Modality Therapy
- Endometrial Neoplasms
(chemically induced)
- Estrogens
- Female
- Follow-Up Studies
- Humans
- Mastectomy, Segmental
- Middle Aged
- Multicenter Studies as Topic
(statistics & numerical data)
- Neoplasm Recurrence, Local
(epidemiology, prevention & control)
- Neoplasms, Hormone-Dependent
(drug therapy, epidemiology, mortality, pathology, radiotherapy, surgery)
- Neoplasms, Second Primary
(epidemiology, prevention & control)
- Radiotherapy, Adjuvant
- Randomized Controlled Trials as Topic
(statistics & numerical data)
- Receptors, Estrogen
(analysis)
- Risk Assessment
- Selective Estrogen Receptor Modulators
(adverse effects, therapeutic use)
- Tamoxifen
(adverse effects, therapeutic use)
- Treatment Outcome
|